Identification of novel inhibitors of bacterial translation elongation factors

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 1, 2005, Pages 131-136

  Jayasekera, Maithri M K ^a   Onheiber, Keysha ^a   Keith, John ^a   Venkatesan, Hariharan ^a   Santillan, Alejandro ^a   Stocking, Emily M ^a   Tang, Liu ^a   Miller, Jennifer ^a   Gomez, Leslie ^a   Rhead, Brooke ^a   Delcamp, Tavner ^a   Huang, Shaoming ^a   Wolin, Ronald ^a   Bobkova, Ekaterina V ^a   Shaw, Karen Joy ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; ELONGATION FACTOR; ELONGATION FACTOR TS; ELONGATION FACTOR TU; GUANIDINE DERIVATIVE; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG SPECIFICITY; HIGH THROUGHPUT SCREENING; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; SCINTILLATION; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; TRANSLATION REGULATION;

ANTI-BACTERIAL AGENTS; BENZIMIDAZOLES; DIPEPTIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; GUANIDINES; IMIDAZOLES; INDOLES; MACROMOLECULAR SUBSTANCES; MICROBIAL SENSITIVITY TESTS; PEPTIDE ELONGATION FACTOR TU; PEPTIDE ELONGATION FACTORS; PROTEIN BIOSYNTHESIS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 19944429467     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.1.131-136.2005     Document Type: Article

References (18)

1. Abel, K., M. D. Yoder, R. Hilgenfeld, and F. Jurnak. 1996. An alpha to beta conformational switch in EF-Tu. Structure 4:1153-1159.
2. Berchtold, H., L. Reshetnikova, C. O. A. Reiser, N. K. Schirmer, M. Sprinzl, and R. Hilgenfeld. 1993. Crystal structure of active elongation factor Tu reveals major domain rearrangements. Nature 365:126-132.
3. Gordon, J. 1968. A stepwise reaction yielding a complex between a supernatant fraction from E. coli, guanosine 5′-triphosphate, and aminoacyl-sRNA. Proc. Natl. Acad. Sci. USA 59:179-183.
4. Heffron, S. E., and F. Jurnak. 2000. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 Å resolution: atomic basis for GE2270A inhibition of EF-Tu. Biochemistry 39:37-45.
5. Kariv, I., H. Cao, P. D. Marvil, E. V. Bobkova, Y. E. Bukhtiyarov, Y. P. Yan, U. Patel, L. Coudurier, K. R. Oldenburg, and T. D. Y. Chung. 2001. Identification of the inhibitors of bacterial transcription/translation machinery utilizing the miniaturized 1536-well format screen. J. Biomol. Screen. 6:233-243.
6. Kawashima, T., C. Berthet-Colominas, M. Wulff, S. Cusack, and R. Leberman. 1996. The structure of the Escherichia coli EF-Tu/EF-Ts complex at 2.5 Å resolution. Nature 379:511-518.
7. Kjeldgaard, M., and J. Nyborg. 1992. Refined structure of elongation factor EF-Tu from Escherichia coli. Mol. Biol. 223:721-742.
8. Kjeldgaard, M., P. Nissen, S. Thirup, and J. Nyborg. 1993. The crystal structure of elongation factor EF-Tu from Thermus aquaticus in the GTP conformation. Structure 1:35-50.
9. Knudsen, C., H. Wieden, and M. V. Rodnina. 1991. The importance of structural transitions of the switch II region for the functions of EF-Tu on the ribosome. J. Biol. Chem. 276:22183-22190.
10. Lucas-Lenard, J., and F. Lipmann. 1966. Separation of three microbial amino acid polymerization factors. Proc. Natl. Acad. Sci. USA 55:1562-1566.
11. Mesters, J. R., L. A. H. Zeef, R. Hilgenfeld, J. M. de Graat, B. Kraal, and L. Bosch. 1994. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli. EMBO J. 13:4877-4885.
12. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Nissen, P., M. Kjeldgaard, S. Thirup, G. Polekhina, L. Reshetnikova, B. Clark, and J. Nyborg. 1995. Crystal structure of the ternary complex of Phe-tRNAPhe, EF-Tu, and a GTP analog. Science 270:1464-1472.
14. Polekhina, G., S. Thirup, M. Kjeldgaard, P. Nissen, C. Lippman, and J. Nyborg. 1996. Helix unwinding in the effector region of elongation factor EF-Tu-GDP. Structure 4:1141-1151.
15. Ravel, J. M., R. L. Shorey, C. W. Garner, R. C. Dawkins, and W. Shive. 1969. The role of an aminoacyl-tRNA-GTP-protein complex in polypeptide synthesis. Cold Spring Harbor Symp. Quant. Biol. 34:321-330.
16. Vogeley, L., G. F. Palm, J. R. Mesters, and R. Hilgenfeld. 2001. Conformational change of EF-Tu induced by antibiotic binding. J. Biol. Chem. 276:17149-17155.
17. Zhang, Y., J. Tao, M. Zhou, Q. Meng, L. Zhang, L. Shen, R. Klein, and D. L. Miller. 1997. Elongation factor Ts of Chlamydia trachomatis: structure of the gene and properties of the protein. Arch. Biochem. Biophys. 344:42-52.
18. Zhang, Y., N. Yu, and L. L. Spremulli. 1998. Functional analysis of the roles of residues in E. coli EF-Ts in the interaction with EF-Tu. J. Biol. Chem. 273:4556-4562.